Other Assets, Noncurrent in USD of Regulus Therapeutics Inc. from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Regulus Therapeutics Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2011 to Q2 2024.
  • Regulus Therapeutics Inc. Other Assets, Noncurrent for the quarter ending 30 Jun 2024 was $21K.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Regulus Therapeutics Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $21K 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $74K 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $0 $0 31 Dec 2023 10-Q 08 Aug 2024
Q4 2022 $0 -$291K -100% 31 Dec 2022 10-K 23 Mar 2023
Q3 2022 $0 $0 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $0 $0 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $148K +$148K 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $291K +$267K +1113% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $0 -$333K -100% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $0 -$387K -100% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 $0 -$439K -100% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $24K -$463K -95.1% 31 Dec 2020 10-K 11 Mar 2022
Q3 2020 $333K -$203K -37.9% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $387K +$360K +1333% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $439K +$306K +230% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 $487K +$161K +49.4% 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $536K +$209K +63.9% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $27K -$301K -91.8% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $133K -$487K -78.5% 31 Mar 2019 10-Q 10 May 2019
Q4 2018 $326K -$264K -44.7% 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $327K +$20K +6.52% 30 Sep 2018 10-Q 09 Nov 2018
Q2 2018 $328K -$12K -3.53% 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 $620K +$285K +85.1% 31 Mar 2018 10-Q 10 May 2018
Q4 2017 $590K +$248K +72.5% 31 Dec 2017 10-K 18 Mar 2019
Q3 2017 $307K -$36K -10.5% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 $340K +$30K +9.68% 30 Jun 2017 10-Q 02 Aug 2017
Q1 2017 $335K -$19K -5.37% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 $342K -$2K -0.58% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 $343K -$1.73M -83.5% 30 Sep 2016 10-Q 02 Nov 2016
Q2 2016 $310K -$1.48M -82.7% 30 Jun 2016 10-Q 03 Aug 2016
Q1 2016 $354K -$1.45M -80.3% 31 Mar 2016 10-Q 03 May 2016
Q4 2015 $344K -$1.47M -81% 31 Dec 2015 10-K 03 Mar 2017
Q3 2015 $2.08M +$1.04M +100% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $1.79M +$817K +83.6% 30 Jun 2015 10-Q 05 Aug 2015
Q1 2015 $1.8M +$822K +84% 31 Mar 2015 10-Q 08 May 2015
Q4 2014 $1.81M +$824K +83.5% 31 Dec 2014 10-K 23 Feb 2016
Q3 2014 $1.04M +$860K +483% 30 Sep 2014 10-Q 06 Nov 2014
Q2 2014 $977K +$573K +142% 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 $978K +$788K +415% 31 Mar 2014 10-Q 09 May 2014
Q4 2013 $987K +$862K +690% 31 Dec 2013 10-K 19 Feb 2015
Q3 2013 $178K -$1.92M -91.5% 30 Sep 2013 10-Q 14 Nov 2013
Q2 2013 $404K 30 Jun 2013 10-Q/A 16 Aug 2013
Q1 2013 $190K 31 Mar 2013 10-Q 15 May 2013
Q4 2012 $125K $0 0% 31 Dec 2012 10-K 28 Feb 2014
Q3 2012 $2.1M 30 Sep 2012 10-Q 19 Nov 2012
Q4 2011 $125K 31 Dec 2011 10-K 19 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.